Xolair Treatment for Milk Allergic Children

NCT00968110 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Milk Allergy

Interventions

DRUG: omalizumab

Sponsor

Boston Children's Hospital

Collaborators

[object Object]